Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
UK Trial of Radioiodine Intervention in Subclinical Hyperthyroidism
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN66874446
Date ISRCTN assigned08/08/2006
Local reference number(s)G0500783
Public titleUK Trial of Radioiodine Intervention in Subclinical Hyperthyroidism
Scientific title
AcronymTRISH
Disease/condition/study domainSubclinical hyperthyroidism
Study hypothesisRadioiodine treatment for sustained subclinical hyperthyroidism will not reduce circulatory endpoints in the elderly.
Design/methodologyRandomised controlled trial
Research ethics reviewApproval gained from the Newcastle and North Tyneside Research Ethics Committee (reference number: 06/Q0905/112).
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Over 65 years of age
2. Sustained subclinical hyperthyroidism (undetectable Thyroid Stimulating Hormome [TSH], normal free thyroid
hormones) for greater than three months
Participants - exclusion criteria1. Patient currently has or has ever had Atrial Fibrillation (AF)
2. Certain drug usage
3. Pituitary, severe renal or hepatic disease
4. Unstable coronary disease
Patient information material
Anticipated start date01/10/2006
Anticipated end date30/09/2015
Status of trialOngoing
Target number of participants780
InterventionsRadioiodine treatment versus usual care.
Primary outcome measure(s)Composite circulatory mortality
Secondary outcome measure(s)1. All cause mortality
2. Atrial fibrillation
3. Progression to overt
hyperthyroidism
4. Hip and vertebral fractures
5. MMTS
Sources of fundingMedical Research Council (UK)
Sponsor nameNewcastle upon Tyne Hospitals NHS Trust (UK)
Sponsor detailsResearch and Development Department
Clinical Research Facility
Leazes Wing, 4th Floor
Royal Victoria Infirmary
Newcastle upon Tyne
United Kingdom
NE1 4LP
Contact nameDr Simon Pearce
Contact detailsSchool of Clinical Medical Sciences
University of Newcastle
Newcastle upon Tyne
United Kingdom
NE2 4HH
Contact emails.h.s.pearce@ncl.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN66874446
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central